D
Phathom Pharmaceuticals, Inc. PHAT
$4.41 $0.194.50%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 8,001.47% -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue 8,001.47% -- -- -- --
Cost of Revenue 4,674.25% -- -- -- --
Gross Profit 9,080.39% -- -- -- --
SG&A Expenses 146.48% 195.74% 137.93% 62.39% 16.76%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 98.05% 118.07% 74.04% 27.44% -2.58%
Operating Income -65.84% -99.84% -67.47% -25.87% 2.97%
Income Before Tax -65.84% -91.70% -60.67% -26.56% -1.96%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -65.84% -91.70% -60.67% -26.56% -1.96%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -65.84% -91.70% -60.67% -26.56% -1.96%
EBIT -65.84% -99.84% -67.47% -25.87% 2.97%
EBITDA -65.93% -100.07% -67.67% -25.96% 2.96%
EPS Basic -37.69% -48.61% -16.99% 9.39% 22.99%
Normalized Basic EPS -37.69% -48.61% -16.99% 9.39% 22.99%
EPS Diluted -37.69% -48.61% -16.99% 9.39% 22.99%
Normalized Diluted EPS -37.69% -48.61% -16.99% 9.39% 22.99%
Average Basic Shares Outstanding 23.26% 26.41% 35.10% 37.44% 31.00%
Average Diluted Shares Outstanding 23.26% 26.41% 35.10% 37.44% 31.00%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings